Carl Zeiss Meditec AG
- WKN: 531370
- ISIN: DE0005313704
- Land: Deutschland
Nachricht vom 12.07.2018 | 16:06
Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management Board
JENA, July 12, 2018.
Effective 30 September 2018, Dr. Christian Müller will leave the Management Board of Carl Zeiss Meditec AG (FSE: AFX) and, on 1 October 2018, will become Chief Financial Officer (CFO) of Carl Zeiss AG. Müller has served as CFO of Carl Zeiss Meditec AG since 2009. He came to Carl Zeiss Meditec AG in 2006 where he headed the newly created Surgical Ophthalmology strategic business unit. The Supervisory Board of Carl Zeiss Meditec AG has appointed Justus Felix Wehmer as CFO of Carl Zeiss Meditec AG, also effective 1 October 2018. Mr. Wehmer is currently CFO and Co-Head of the ZEISS Microscopy business group.
In addition, effective 1 October 2018, the Management Board of Carl Zeiss Meditec AG will be expanded from two to three members with the appointment of Jan Willem de Cler. Mr. de Cler has been at ZEISS since 2004 and currently heads Surgical Ophthalmology within Carl Zeiss Meditec AG. As Member of the Management Board, his responsibilities will include Human Resources and Employee Development.
"We are particularly pleased that we were able to appoint long-time employees from the ZEISS Group to these positions. This will ensure that we can continue driving our current strategy. The Supervisory Board would like to thank Dr. Christian Müller for his excellent work over the past nine years and wishes Mr. Wehmer and Mr. de Cler much success with their new positions," said Prof. Dr. Michael Kaschke, Chairman of the Supervisory Board of Carl Zeiss Meditec AG.
Dr. Christian Müller has been CFO and Member of the Management Board of Carl Zeiss Meditec AG since 2009. He is responsible for Finance and Controlling, Investor Relations, and Legal and Taxes. He also oversees Service, Quality Management and Regulatory Affairs. Dr. Müller joined the ZEISS Group in 2002 as Vice-President of Corporate Auditing and Risk Management. In 2006, he transferred to Carl Zeiss Meditec AG where he headed the newly created Surgical Ophthalmology strategic business unit with sites in Germany, France and Scotland. He previously served as head of finance at Degussa AG starting in 1999 and, from 1997, as department head for auditing and risk management at VIAG AG. He began his professional career at the auditing company C&L Deutsche Revision in 1992. Dr. Christian Müller holds a degree in business administration and completed his Ph.D. at the University of Frankfurt am Main in 1996.
Justus Felix Wehmer has served as Co-Head of the Microscopy business group and Managing Director of Carl Zeiss Microscopy GmbH since 2015. He headed Carl Zeiss Jena GmbH beginning in 2013. Prior to this, he was vice-president of finance and strategy and general manager at NXP Semiconductors Germany GmbH in Hamburg. He had already worked at ZEISS in the period from 2002 to 2012 - initially as Senior Vice-President for Finance at the Industrial Metrology business group and, from 2007, he held the same position at the Semiconductor Manufacturing Technology business group. Justus Felix Wehmer studied business administration at the Academy of Business and Administration in Essen and was awarded an MBA by the London Business School in 1995.
Jan Willem de Cler has been Head of Surgical Ophthalmology at Carl Zeiss Meditec AG since 2010. He came to ZEISS in 2004 as Managing Director of the Benelux sales and service company. He also served as Managing Director of the sales and service company in France and of France Chirurgie Instrumentation (FCI). In January 2014, he was responsible for the strategic acquisition of the American company Aaren Scientific Inc., which enabled the further globalization of the surgical ophthalmology business. Jan Willem de Cler studied marketing and management at Nijenrode University in the Netherlands and earned an MBA in international business from the University of Oregon, USA. After holding different positions at General Electric and GE Medical Systems, he became co-founder and head of sales & marketing for the startup Global Healthcare Exchange Europe.
Contact for investors and press
End of Media Release
Issuer: Carl Zeiss Meditec AG
Key word(s): Enterprise
|Company:||Carl Zeiss Meditec AG|
|Göschwitzer Str. 51-52|
|Phone:||+49 (0)3641 220-0|
|Fax:||+49 (0)3641 220-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP Media|
Continued profitable growth for Carl Zeiss Med ...
Carl Zeiss Meditec AG: Bekanntmachung der Einb ...
Carl Zeiss Meditec AG: Preliminary announcemen ...
Carl Zeiss Meditec AG acieves strong revenue a ...
Carl Zeiss Meditec continues on growth course ...
UniDevice AG: Rekord-Ergebnis in 2018
Nach starkem Schlussspurt hat die UniDevice AG in 2018 Umsatz und Ergebnis deutlich gesteigert. Der B2B-Broker für hochpreisige Smartphones sollte auch künftig eine hohe Nachfrage verzeichnen und von der Ausnutzung unterschiedlicher Preisniveaus in den verschiedenen Ländern profitieren. Der Umsatz soll 2019 auf mindestens 380 Mio. € und in 2020 auf mindestens 410 Mio. € ansteigen, nachdem 2018 317 Mio. € erreicht wurden. Bei einem ermittelten Kursziel in Höhe von 2,35 € lautet das Rating KAUFEN.
Der AKTIONÄR News
20. Februar 18:12 Baidu: Ein Riesenproblem für Anleger
20. Februar 18:00 Wirecard: Exklusiv-Interview – Ehssan Khazaeli will Dan McCrum zur ...
20. Februar 17:57 Das unfassbare Silber-Kursziel
20. Februar 17:52 Wettrennen in der Cloud – Microsoft und Google holen auf
20. Februar 17:05 Tesla-Rivale: Aktie heute +40% - Musk kontert mit ...
News im Fokus
Fresenius Medical Care gibt Ausscheiden von Finanzvorstand Michael Brosnan bekannt
20. Februar 2019, 10:29
Vorläufige Geschäftszahlen 2018
26. Februar 2019
Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index
20. Februar 2019